IPRIPR2016-01665Final Written Decision
Amerigen Pharmaceuticals Limited et al.v.UCB Pharma GmbH
IPR challenge of US 6858650.
Type
IPR
Filed
Aug 22, 2016
Instituted
Dec 7, 2016
Decided
—
Patent
Application
10130214
Inventor
Claus Meese
Granted
Feb 22, 2005
01
Timeline
3 milestones
2016-08-22Petition filed
2016-12-07Institution
2017-07-19Terminated
02
Parties & counsel
Petitioner
Amerigen Pharmaceuticals Limited et al.
Counsel
Hare, William
Patent Owner
UCB Pharma GmbH
Counsel
Oelke, Jeffreyet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →